PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28500233-0	2017	Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation.	olaparib	19-27	phosphatase and tensin homolog	Mus musculus	69-73	
24222661-2	2013	Here, we test the efficacy of AZD2281 (olaparib), an oral PARP inhibitor, in the therapy of PTEN-null endometrial tumors in a preclinical endometrial cancer mouse model.	olaparib	30-37	phosphatase and tensin homolog	Mus musculus	92-96	
24222661-2	2013	Here, we test the efficacy of AZD2281 (olaparib), an oral PARP inhibitor, in the therapy of PTEN-null endometrial tumors in a preclinical endometrial cancer mouse model.	olaparib	39-47	phosphatase and tensin homolog	Mus musculus	92-96	
30555227-6	2018	Methods: The tumor cell line 404, which was derived from a Brca2 -/-, Tp53 -/-, Pten -/- genetically engineered mouse model, exhibited high sensitivity to Olaparib in vitro.	olaparib	155-163	phosphatase and tensin homolog	Mus musculus	80-84